Showing results (321-330 of 332) with videos related to
Sort By:
Pageof 34
Eye (London, England)|May 6, 2024
Impact of treat and extend criteria on proportions that can be extended after loading phase of 2 mg aflibercept therapy for neovascular age related macular degeneration: PRECISE Report 5Sridevi Thottarath, Sarega Gurudas, Swati Chandak, et al.BMJ Open|March 7, 2024
Descriptive study of the challenges when implementing an app for patients with neovascular age-related macular degeneration to monitor their vision at homeBarnaby C Reeves, Robin Wickens, Sean R O'Connor, et al.Eye (London, England)|December 15, 2023
Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3Shruti Chandra, Sarega Gurudas, Ian Pearce, et al.Proceedings of the National Academy of Sciences of the United States of America|June 22, 2026
Hypoxia-mediated epicardial signaling coordinates coronary angiogenesis and myocardial expansion during zebrafish ventricle maturationKu-Chi Tsao, Isaac Bakis, Shuofei Sun, et al.Eye (London, England)|May 6, 2020
Monitoring for neovascular age-related macular degeneration (AMD) reactivation at home: the MONARCH studyElizabeth Ward, Robin A Wickens, Abby O'Connell, et al.Eye (London, England)|April 23, 2024
Subretinal transient hyporeflectivity in neovascular age-related macular degeneration and its response to a loading phase of aflibercept: PRECISE report 4Andrea Montesel, Raheeba Pakeer Muhammed, Swati Chandak, et al.Eye (London, England)|October 18, 2023
Associations of presenting visual acuity with morphological changes on OCT in neovascular age-related macular degeneration: PRECISE Study Report 2Shruti Chandra, Sarega Gurudas, Benjamin J L Burton, et al.International Journal of Environmental Research and Public Health|October 27, 2022
Patient Acceptability of Home Monitoring for Neovascular Age-Related Macular Degeneration Reactivation: A Qualitative StudySeán R O'Connor, Charlene Treanor, Elizabeth Ward, et al.Journal of Clinical Medicine|April 28, 2023
A Multi-Modal AI-Driven Cohort Selection Tool to Predict Suboptimal Non-Responders to Aflibercept Loading-Phase for Neovascular Age-Related Macular Degeneration: PRECISE Study Report 1Michal Chorev, Jonas Haderlein, Shruti Chandra, et al.International Journal of Environmental Research and Public Health|August 12, 2022
The COVID-19 Pandemic and Ophthalmic Care: A Qualitative Study of Patients with Neovascular Age-Related Macular Degeneration (nAMD)Seán R O'Connor, Charlene Treanor, Elizabeth Ward, et al.Pageof 34